secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rapport Therapeutics, Inc. (RAPP)
CIK:        0002012593
Form:       8-K
Filed at:   2026-01-07T23:59:59+00:00
Accession:  0001193125-26-005499
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapport Therapeutics registers up to $110M in at-the-market stock offering
--------------------------------------------------------------------------

- Filed prospectus supplement on Jan 7, 2026 to sell up to $110M of common stock through Leerink and Cantor Fitzgerald.
- Sales would be made under existing Sales Agreement dated July 1, 2025; no sales have occurred to date.
- Legal opinion from Goodwin Procter LLP filed as Exhibit 5.1.
- Offering is for general corporate purposes; no specific use of proceeds disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2012593/000119312526005499/0001193125-26-005499-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2012593/000119312526005499/rapp-20260107.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-005499

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer